U.S. Marine and Shipping Stock News

Wondering if Apollo Global Management at around US$109.98 is offering good value, or if the market is asking too much for the stock right now. The share price has seen a 1.2% decline over the last week and 3.6% over the past month, set against a 25.0% decline year to date and a 21.4% decline over the last year. The 3 year and 5 year returns sit at 88.1% and 154.6% respectively. Recent headlines around Apollo Global Management have focused on its role as a major diversified financial player...

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may offer potential opportunities for investors seeking alignment of interests.

SouthState Bank (NYSE:SSB) announces a new share repurchase plan approved by its board. The company pairs the buyback authorization with CEO comments pointing to strong business performance. An analyst upgrade follows, signaling increased confidence in SouthState Bank's outlook. SouthState Bank, a regional banking franchise listed on the NYSE under the ticker SSB, operates in a sector that has been closely watched for capital returns, credit quality and funding costs. A fresh share...

Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.

Why Oceaneering International (OII) Is On Investors’ Radar Today Recent performance in Oceaneering International (OII) has caught investor attention, with the stock showing a mix of strong past 3 months and 1 year total returns alongside a weaker month. Against that backdrop, the company’s US$2.8b in revenue and US$353.8m in net income, spread across offshore energy and defense related segments, provide a broad based business to assess beyond short term share price moves. See our latest...

Over the last 7 days, the United States market has experienced a slight dip of 1.6%, yet it remains robust with a 15% increase over the past year and anticipated earnings growth of 16% per annum in the coming years. In this dynamic environment, identifying stocks that are undervalued or overlooked can provide unique opportunities for investors seeking to capitalize on emerging potential within a thriving market.

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has seen a notable increase of 15% over the past year, with earnings expected to grow by 16% annually. In this dynamic environment, selecting dividend stocks that offer both stability and growth potential can be an effective strategy for investors seeking reliable income streams and long-term value.

One thing we could say about the covering analyst on Perma-Fix Environmental Services, Inc. ( NASDAQ:PESI ) - they...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Readers hoping to buy Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) for its dividend will need to make their move shortly...

Even if it's not a huge purchase, we think it was good to see that Edward Stenger, the Independent Director of Team...

LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) just released its latest yearly report and things are not looking great. It was...

The Morning Bull - US Market Morning Update Friday, Mar, 27 2026 US stock futures are mixed this morning, with S&P 500 contracts hovering near flat as investors weigh higher borrowing costs against hotter inflation and geopolitical risk. The US 10 year Treasury yield is holding around 4.41%, which keeps pressure on everything from credit cards to business loans, while the average 30 year mortgage rate sits at 6.38%, keeping home buying more expensive. At the same time, Middle East tensions...

This article examines whether Raymond James Financial at around US$144.20 is offering good value or is priced too high, and walks through what the current price might imply. The stock is up 0.9% over the last 7 days, while the 30 day and year to date returns of a 7.3% decline and an 11.9% decline compare with a 1 year return of 2.4% and a 3 year gain of 63.5% that extends to 82.9% over 5 years. Recent coverage has focused on Raymond James Financial's role within the broader capital markets...

SIGA Technologies (NasdaqGM:SIGA) has declared a special cash dividend for its shareholders. The announcement provides a direct cash return in addition to any regular dividend policy the company may have. The timing of the dividend decision highlights management's current view of the company’s cash position and capital needs. SIGA Technologies focuses on health security solutions, including products designed for infectious disease and biodefense settings. A special cash dividend draws...

We feel now is a pretty good time to analyse Prothena Corporation plc's ( NASDAQ:PRTA ) business as it appears the...

If you are wondering whether Compass Minerals International at around US$23.82 is still priced attractively after its recent run, the key question is how its current share price lines up against its fundamentals. The stock has returned 8.3% over the past week and 19.9% year to date. However, this sits alongside a 2.5% decline over the past month and longer term returns of 150.5% over 1 year, a 26.2% decline over 3 years, and a 60.4% decline over 5 years. Recent coverage has highlighted...

Delta Air Lines (NYSE:DAL) has suspended expedited airport screening and escort services for members of Congress. The pause is tied to the current US government shutdown and cost pressures affecting airline operations. The change is contributing to longer TSA lines and a wider debate about travel privileges for public officials. Delta Air Lines, traded as NYSE:DAL, is a major US carrier focused on passenger and cargo air travel. The decision to suspend special treatment for lawmakers comes...

LCI Industries stock in focus after recent performance shifts LCI Industries (LCII) has drawn investor attention following mixed recent share performance, with a small gain over the past week contrasting with a loss over the past month and flat movement over the past 3 months. See our latest analysis for LCI Industries. Looking beyond the recent swings, the 1 year total shareholder return of 41.45% and 3 year total shareholder return of 31.07% point to momentum that contrasts with the weaker...

Kratos Defense & Security Solutions (NasdaqGS:KTOS) received a new contract from the U.S. Navy's Naval Surface Warfare Center to produce and deliver advanced Oriole solid rocket motors. The award supports missile defense and hypersonic testing programs that use the Oriole system. Kratos also appointed defense industry veteran David King to its Board of Directors. King brings extensive experience growing defense businesses and overseeing large aerospace programs. For investors watching the...

We wouldn't blame Best Buy Co., Inc. ( NYSE:BBY ) shareholders if they were a little worried about the fact that Corie...

Celcuity (NasdaqCM:CELC) received FDA Priority Review for its New Drug Application for gedatolisib in advanced breast cancer. The Priority Review follows strong Phase 3 efficacy results from the VIKTORIA-1 trial in HR-positive, HER2-negative breast cancer. An additional Phase 3 readout for the PIK3CA mutant cohort is upcoming and could further influence treatment standards for this patient group. Celcuity focuses on targeted therapies for cancer, with gedatolisib as a key asset in its...

Leadership reshuffle puts technology and deal-making in focus Royalty Pharma (RPRX) has refreshed its senior ranks, naming Lucas Glass as Head of Artificial Intelligence and bringing in Greg Butz as Executive Vice President, Partnering & Investments, while also reinforcing its leadership presence in Asia. See our latest analysis for Royalty Pharma. At a share price of US$46.94, Royalty Pharma has posted a 19.68% 90 day share price return and a 51.83% 1 year total shareholder return, as...

If you are wondering whether Centene's current share price offers value or just more volatility, it helps to break the story down into what the market has been pricing in and how that compares with fundamentals. The stock closed at US$33.56, with returns of a 5.7% decline over 7 days, a 20.8% decline over 30 days, a 19.7% decline year to date, a 44.3% decline over the last year, a 47.7% decline over 3 years and a 46.9% decline over 5 years. This history sets a very specific backdrop for any...